Group
PARP inhibitor
The data below refer to patients treated with PARP inhibitor as the sole drug class,
excluding any concurrent use of drugs from other groups.
Location
Treated site
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.